Compare MGTX & JFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MGTX | JFR |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2018 | N/A |
| Metric | MGTX | JFR |
|---|---|---|
| Price | $14.34 | $7.54 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $24.57 | N/A |
| AVG Volume (30 Days) | 528.7K | ★ 548.0K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.31% |
| EPS Growth | ★ 33.02 | N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $81,391,000.00 | N/A |
| Revenue This Year | $141.38 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.18 | ★ N/A |
| Revenue Growth | ★ 144.57 | N/A |
| 52 Week Low | $6.62 | $7.16 |
| 52 Week High | $15.35 | $8.45 |
| Indicator | MGTX | JFR |
|---|---|---|
| Relative Strength Index (RSI) | 64.13 | 35.14 |
| Support Level | $7.04 | $7.44 |
| Resistance Level | $15.35 | $7.60 |
| Average True Range (ATR) | 0.67 | 0.06 |
| MACD | 0.18 | -0.02 |
| Stochastic Oscillator | 76.40 | 5.00 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income. The fund invests a majority of its managed assets in secured Senior Loans and unsecured Senior Loans, with an average duration of one year or less, in which unsecured Senior Loans will be, at the time of investment, investment grade quality.